Evidence map›Paper›PMID 27274008›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2016

HLA-DRB1 Amino Acid Positions 11/13, 71, and 74 Are Associated With Inflammation Level, Disease Activity, and the Health Assessment Questionnaire Score in Patients With Inflammatory Polyarthritis.

Stephanie F Ling, Sebastien Viatte, Mark Lunt, Alper M Van Sijl, Lucia Silva-Fernandez, Deborah P M Symmons, Adam Young, Alexander J Macgregor, Anne Barton

Open access · hybridAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Lifestyles, metabolome and diabetic kidney disease: a cohort study.QJM : monthly journal of the Association of Physicians · 2026
    Article
  5. Article
  6. Frontiers in immunology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Review
  19. Article
  20. CD28Theranostics · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Stephanie F LingUniversity of Manchester, Manchester, UK.
Sebastien ViatteUniversity of Manchester, Manchester, UK.
Mark LuntUniversity of Manchester, Manchester, UK.
Alper M Van SijlUniversity of Manchester, Manchester, UK, and Jan van Breemen Research Institute Reade, Amsterdam, The Netherlands.
Lucia Silva-FernandezUniversity of Manchester, Manchester, UK, and Complexo Hospitalario Universitario de Ferrol, A Coruña, Spain.
Deborah P M SymmonsUniversity of Manchester and Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Adam YoungSt. Albans City Hospital, St. Albans, UK, and University of Hertfordshire, Hatfield, UK.
Alexander J MacgregorUniversity of East Anglia, Norwich, UK.
Anne BartonUniversity of Manchester and Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK. anne.barton@manchester.ac.uk.
University of Manchester · GBManchester University NHS Foundation Trust · GBComplexo Hospitalario Universitario A Coruña · ESReade · NLSt Albans City Hospital · GBUniversity of East Anglia · GB

Funding

Arthritis Research UK 20385Arthritis Research UK 21229
6 · The paper itself

Abstract

objectiveRheumatoid arthritis (RA) susceptibility HLA-DRB1 haplotypes based on amino acid positions 11/13, 71, and 74 predict radiographic damage. The mechanism of action is unknown, but it may be mediated by inflammation. We undertook this study to systematically investigate the effect of these amino acids on nonradiographic measures of disease activity/outcomes.

methodsWe tested the association of RA susceptibility HLA-DRB1 amino acids with the C-reactive protein (CRP) level, the tender joint count (TJC), the swollen joint count (SJC), the Disease Activity Score in 28 joints (DAS28), and the Health Assessment Questionnaire (HAQ) score in the Norfolk Arthritis Register (NOAR) and Early Rheumatoid Arthritis Study (ERAS) cohorts. Longitudinal modeling of disease activity/outcomes was performed using generalized linear latent and mixed models. Mediation analysis was performed using directed acyclic graphs to investigate the paths from genetic factors to outcome.

resultsA total of 2,158 patients were available for analysis in the NOAR cohort. Valine at position 11 showed the strongest association with the CRP level (P = 2.21 × 10

conclusionGenetic markers of RA susceptibility located within HLA-DRB1 determine the levels of clinical and systemic inflammation independently, and also determine all objective measures of disease activity and outcome.

Indexed as

AdultAgedAllelesAmino AcidsAntirheumatic AgentsArthritisArthritis, RheumatoidCohort StudiesC-Reactive ProteinFemaleGenotypeHaplotypesHLA-DRB1 ChainsHumansInflammationLongitudinal StudiesAmino AcidsAntirheumatic AgentsC-Reactive Proteincyclic citrullinated peptideHLA-DRB1 ChainsPeptides, Cyclic

Identifiers

PMID27274008
PMCPMC5244675
OpenAlexW2410068664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.